INFI - Infinity Pharmaceuticals beats by $0.03 revenue in-line March, 14 2019 07:36 AM Infinity Pharmaceuticals Inc. Infinity Pharmaceuticals (NASDAQ:INFI): FY GAAP EPS of -$0.20 beats by $0.03.More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, , Read more ...